tiprankstipranks
Arch Biopartners (TSE:ARCH)
:ARCH
Canadian Market

Arch Biopartners (ARCH) Financial Statements

Compare
20 Followers

Arch Biopartners Financial Overview

Arch Biopartners's market cap is currently C$114.18M. The company's EPS TTM is C$-0.055; its P/E ratio is ―; Arch Biopartners is scheduled to report earnings on February 4, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Sep 23Sep 22Sep 21Sep 20
Income Statement
Total RevenueC$ 0.00C$ 1.98MC$ 964.68KC$ 3.89MC$ 67.89K
Gross ProfitC$ 0.00C$ -128.99KC$ -502.88KC$ -149.79KC$ -2.12M
Operating IncomeC$ -3.95MC$ -3.36MC$ -1.39MC$ -1.16MC$ -4.63M
EBITDAC$ -3.53MC$ -335.87KC$ -101.42KC$ -77.02KC$ -4.45M
Net IncomeC$ -3.92MC$ -3.33MC$ -1.08MC$ -1.17MC$ -4.63M
Balance Sheet
Cash & Short-Term InvestmentsC$ 2.97KC$ 831.27KC$ 506.35KC$ 448.24KC$ 653.68K
Total AssetsC$ 935.62KC$ 1.17MC$ 621.64KC$ 2.67MC$ 741.30K
Total DebtC$ 2.77MC$ 5.02MC$ 4.41MC$ 5.16MC$ 3.39M
Net DebtC$ 2.77MC$ 4.18MC$ 3.91MC$ 4.72MC$ 2.74M
Total LiabilitiesC$ 5.28MC$ 6.68MC$ 5.09MC$ 6.55MC$ 4.61M
Stockholders' EquityC$ -4.35MC$ -5.51MC$ -4.47MC$ -3.88MC$ -3.87M
Cash Flow
Free Cash FlowC$ -2.33MC$ -234.08KC$ -1.08MC$ -2.98MC$ -1.90M
Operating Cash FlowC$ 0.00C$ -234.07KC$ -1.08MC$ -2.98MC$ -1.90M
Investing Cash FlowC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Financing Cash FlowC$ 1.50MC$ 559.00KC$ -421.37KC$ 2.78MC$ 2.16M
Currency in CAD

Arch Biopartners Earnings and Revenue History

Arch Biopartners Debt to Assets

Arch Biopartners Cash Flow

Arch Biopartners Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis